PVLA — PALVELLA THERAPEUTICS INC NE

As of Q2 2026, 31 SEC-registered investment managers reported holding PVLA (PALVELLA THERAPEUTICS INC NE) in their latest 13F filings, with a combined reported value of $380.24M across 3.13M shares. That is +20.0% by share count (+521.47K shares) versus the previous quarter, while reported value moved +38.5%. Ownership is concentrated: the five largest holders account for 72.0% of reported value and the top ten for 85.3%.

Compared with the prior quarter, 4 opened new positions, 20 added to existing stakes, 6 trimmed, 2 exited entirely. 13F holdings are quarter-end snapshots, so these moves reflect positioning as of Q2 2026, not real-time trading.

PVLA is classified in the Health Care sector.

All figures on this page are computed from SEC Form 13F quarterly filings. 13F filers disclose long positions of $100,000 or more within 45 days of quarter end; short positions, options overlays and intra-quarter trades are not included, so treat the numbers as a quarterly snapshot of institutional ownership rather than real-time positioning.